semaglutide injection vials Flex-Dose 4 mL Injectable 2.5 mg/mL GLP-1 Weight Loss Options |

[PubMed] [Google Scholar] 77

Richard Hudson (R-NC) and U.S

A phase 1 mechanistic study of people with T2D reported a mean weight change at week 28 of 11.2 kg among participants assigned to tirzepatide 15 mg as compared with 6.9 kg for semaglutide 1.0 mg and no change (0 kg) for placebo [38]

This effect seems to be very important for the normalization of postprandial glucose (PPG) elevations, and potentially even more important than the insulinotropic effects of GLP-1 for maintaining PPG homeostasis [19]

To prevent this, it is important to have regular meals, and always carry a fast-acting source of glucose, such as sugary candy or glucose candy, with you

Minerva Endocrinol (2020) 45:32644